Results 191 to 200 of about 10,317 (226)
Some of the next articles are maybe not open access.
Penicillamine-Induced Ocular Myasthenia Gravis
American Journal of Ophthalmology, 1985Two patients with rheumatoid arthritis (two women, 58 and 62 years old) developed reversible penicillamine-induced ocular myasthenia gravis. Both had the HLA-DR1 antigen, unlike most patients with idiopathic myasthenia gravis who show HLA-DR3, suggesting that penicillamine-induced myasthenia gravis and its idiopathic counterpart occur in patients with ...
M, O'Keefe +3 more
openaire +2 more sources
SFEMG in ocular myasthenia gravis diagnosis
Clinical Neurophysiology, 2000In typical cases, the patient's history and clinical examination make it possible to diagnose ocular myasthenia gravis (OMG). But, in many cases a clear clinical picture is not present and OMG diagnosis is very difficult because gold diagnostic standard tests are not available.
Luca Padua +2 more
exaly +3 more sources
Archives of Neurology, 1997
In their discussion of the results of a retrospective chart review of 32 patients with ocular myasthenia gravis treated with prednisone for variable periods, Kupersmith and colleagues 1 neglected to mention the only controlled clinical trial of anything in myasthenia—namely, of corticotropin.
openaire +1 more source
In their discussion of the results of a retrospective chart review of 32 patients with ocular myasthenia gravis treated with prednisone for variable periods, Kupersmith and colleagues 1 neglected to mention the only controlled clinical trial of anything in myasthenia—namely, of corticotropin.
openaire +1 more source
Ocular Myasthenia Gravis and Hashimoto's Thyroiditis
American Journal of Ophthalmology, 1975Two patients had ocular myasthenia gravis coexistent with Hashimoto's thyroiditis. A 37-year-old woman presented with diplopia and displayed a head tremor and thyroid enlargement. Thyroid function tests showed an elevated thyroid stimulating hormone (TSH).
R H, Osher, J L, Smith
openaire +2 more sources
Therapeutic options in ocular myasthenia gravis
Neuromuscular Disorders, 2001The term ocular myasthenia gravis refers to the disease clinically restricted to extrinsic ocular muscles. It can be disabling as ptosis, and to a greater extent diplopia, both interfere with daily activities. Although ocular disturbances are the most frequent initial complaints in myasthenic patients, symptoms usually progress to generalized disease ...
A, Evoli +4 more
openaire +2 more sources
Strabismus Surgery in Ocular Myasthenia gravis
Ophthalmologica, 1996We evaluated the efficacy of eye muscle surgery in 4 patients with ocular myasthenia gravis with troublesome diplopia. All patients were in remission and had shown a consistently stable angle of deviation for at least 6 months preoperatively. The extent of eye muscle surgery was based on the degree of deviation in the primary position, and conventional
H, Ohtsuki +3 more
openaire +2 more sources
Immunotherapy of Ocular Myasthenia Gravis Reduces Conversion to Generalized Myasthenia Gravis
Journal of Neuro-Ophthalmology, 2003Several retrospective studies have suggested that immunotherapy, including prednisolone, azathioprine and thymectomy, reduces progression of ocular myasthenia gravis to generalized myasthenia gravis. This study examines the effect of immunotherapy on generalization rates in ocular myasthenia patients who are acetylcholine receptor (AChR) antibody ...
Jared, Mee +5 more
openaire +2 more sources
Journal of the National Medical Association, 1994
Ocular dysfunction accounts for nearly 70% of the initial manifestations of myasthenia gravis. Since the prevalence rate of myasthenia gravis is two to 10 cases per 100,000 population, it is important for clinicians to be cognizant of this disorder and its varied ocular presentations.
G A, March, L N, Johnson
openaire +1 more source
Ocular dysfunction accounts for nearly 70% of the initial manifestations of myasthenia gravis. Since the prevalence rate of myasthenia gravis is two to 10 cases per 100,000 population, it is important for clinicians to be cognizant of this disorder and its varied ocular presentations.
G A, March, L N, Johnson
openaire +1 more source
Treatment of ocular symptoms in myasthenia gravis
Neurology, 2008The choice between acetyl-cholinesterase inhibitors (AChE-Is) and steroids as symptomatic therapy for ocular symptoms in myasthenia is controversial.Thirty-five patients with myasthenia and ocular symptoms were evaluated by a single investigator. The ocular-quantitative myasthenia gravis (QMG) score was determined at each visit.
Minal J, Bhanushali +2 more
openaire +2 more sources